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The economic burden of epilepsy is well recognized. However, empirical investigation establishing costs associated with the 
diagnosis and treatment of non-epileptic psychogenic seizures (NEPS) is lacking. We studied 20 patients with video/EEG 
monitoring-confirmed NEPS to determine the effect of definitive diagnosis and treatment on medical costs and utilization. A 
medical resource utilization questionnaire and inpatient medical chart review were employed to calculate utilization information. 
Medication usage, outpatient visits, emergency room admissions, and diagnostic testing over a 6-month pre-diagnosis and a 6- 
month post-diagnosis period were compared. There was an 84% average reduction in total seizure-related medical charges in the 
6 months following NEPS diagnosis. Average diagnostic testing charges declined 76%, average medication charges decreased 
69%, outpatient clinic visits declined 80%, and emergency room visits reduced by 97%. A majority of patients obtaining a 
definitive inpatient video/EEG-seizure-monitoring-confirmed NEPS diagnosis experience substantial reductions in health care 
utilization and dollar costs. 
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INTRODUCTION 
Health care costs associated with the treatment of 
epilepsy approach $1.5 billion for a single cohort 
year’. Unfortunately, 5-25% of the 2 million persons 
treated yearly for epilepsy in the USA are estimated 
to have nonepileptic psychogenic seizures (NEPS)*. 
The lifetime dollar costs associated with undiagnosed 
NEPS may approximate the lifetime dollar costs asso- 
ciated with the treatment of intractable epilepsy which 
is about $100000 per patient’. Overall incidence of 
NEPS has been estimated at 300000 to 400000 lives 
within the USA alone3A. Lifetime dollars costs per pa- 
tient cohort year for a NEPS group could range from 
$110 million to $920 million. To date, the economic 
impact of the diagnosis and treatment of nonepileptic 
psychogenic seizures (NEPS) has not been formally 
established within the US health care system. 
1059-l 31 l/98/050385 + 06 $12.00/O 
Early identification of NEPS is important given the 
potential for misdiagnosis, iatrogenic hazards (e.g. 
antiepilepsy chug treatment), and costly protracted 
medical treatment. NEPS can be suggested by clin- 
ical observation of the patient’s typical paroxysmal 
event’. However, the clinician’s predictive accuracy in 
identifying NEPS prior to inpatient video/EEG mon- 
itoring is approximately 50%*. NEPS diagnosis may 
be determined during single session outpatient ambu- 
latory EEG. NEPS are typically experienced an av- 
erage of 3 to 7 years prior to definitive diagnosis 
from video/EEG inpatient monitoring, suggesting less 
than optimal diagnostic yield from available outpatient 
evaluation5~9. Continuous video/EEG inpatient mon- 
itoring is the standard for definitive NEPS diagnosis, 
but only a small fraction of persons with NEPS receive 
such diagnostic assessment”. The disparity between 
incidence of NEPS and the utilization of continuous 
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video/EEG inpatient monitoring reflects the absence of 
empirically-based information demonstrating the cost- 
effectiveness of inpatient video/EEG monitoring for 
the definitive diagnosis of NEPS. 
The specific aim of this investigation was to doc- 
ument changes in health care utilization patterns and 
costs in a sample of NEPS patients definitively diag- 
nosed through inpatient video/EEG seizure monitor- 
ing. 
MATERIALS AND METHODS 
This investigation was performed at the University 
of Alabama at Birmingham (UAB) Epilepsy Center. 
The program is a tertiary referral center for the region 
and includes an epilepsy surgery program. Diagnostic 
facilities for epilepsy include intensive seizure moni- 
toring with 24-hour continuous video/EEG monitoring, 
magnetic resonance imaging, single photon emission 
tomography, and neuropsychological testing. Study 
patients received their NEPS diagnosis while on the 
inpatient continuous video/EEG seizure monitoring 
unit. All patients recruited for the present study were 
over the age of 18 at the time of their NEPS diagnosis. 
Patients included in this study were referred to the 
UAB inpatient video/EEG seizure monitoring unit by 
his or her family physician or neurologist. The diag- 
nostic question was to identify seizure type or confirm 
suspicion of nonepileptic events. Patients were given 
the diagnosis of NEPS based on inpatient video/BEG 
seizure monitoring recording of at least one typical 
clinical event. Diagnosis of NEPS was determined by 
the attending epileptologist on the UAB seizure moni- 
toring unit, based on the absence of electrographic ac- 
tivity immediately prior to or during a typical event (as 
defined by the patient and/or family members), atypi- 
cal behavior, and no separate evidence to suggest the 
episodes were due to neurologic disorder, incapaci- 
tating or progressive medical illness, or cardiorespi- 
ratory problems. Ictal EEGs were filtered and refor- 
matted in different montages in a careful search for 
epileptiform features. Attention was paid to whether 
seizure onset occurred during sleep or was provoked 
by environmental factors. The presence or absence of 
inter-ictal spikes or post-ictal EEG slowing was con- 
sidered. In addition, all suspected NEPS patients re- 
ceived psychological evaluation as part of their diag- 
nostic workup. The psychological evaluation consisted 
of standardized psychometric testing and a diagnostic 
interview with the patient and available family’ ‘3 I*. 
Communication of NEPS diagnosis was provided by 
the Epilepsy Center treatment team, with primary re- 
sponsibility for diagnostic communication to the pa- 
tient by the attending physician. Each patient received 
feedback from the clinical psychologist regarding their 
diagnosis. Patients were assisted in obtaining outpa- 
tient psychiatric/mental health referrals in their home 
area. 
Patients 
We attempted to contact a series of 44 adult patients 
who were definitively diagnosed as having NEPS while 
at the UAB seizure monitoring unit. Patients were con- 
tacted between 6 and 8 months from the time of their 
hospital discharge. A total of 20 patients from this se- 
ries volunteered to provide information on their health 
care utilization before and after definitive NEPS diag- 
nosis. We were unable to contact 24 of these patients 
due to a number of issues including unlisted telephone 
numbers or change of address (11 patients), not retum- 
ing telephone messages (eight patients), or declined 
participation (four patients). One patient was deceased 
at time of telephone contact (unrelated medical condi- 
tion). 
No patient in the present sample had a history or 
electrophysiological evidence to indicate co-existing 
epilepsy. Patients were told that their participation was 
voluntary and that the information provided was con- 
fidential. 
Establishment of NEPS-related health care 
utilization variables and cost figures 
Dollar charges were tabulated for standard epilepsy- 
related health care cost variables which included med- 
ication usage, outpatient clinic visits, standard diagnos- 
tic testing (EEG, magnetic resonance imaging (MRI), 
computerized tomography (CT)), laboratory testing 
(blood serum levels, AED levels), and emergency room 
visit charges’. Medication prices were estimated by 
contacting three area pharmacies and obtaining price 
quotes on several standard antiepileptic medications. 
Medication charges were calculated by averaging the 
three price quotes. Outpatient clinic charges (physi- 
cian charges and facility charges) were established 
through price quotes obtained from the UAB Outpa- 
tient Clinic administrative office. Diagnostic testing 
and emergency room charges were determined from 
information obtained through the UAB hospital busi- 
ness administrative office. Diagnostic testing charges 
included facility fees and physician charges. Emer- 
gency room charges were based upon estimates from a 
sample of 10 emergency room admissions for seizures 
(not including status epilepticus diagnosis) that had oc- 
curred over the past 6 months at our university hospital. 
Health care utilization rates were requested for the 
6-month time period preceding inpatient video/EEG 
seizure monitoring and the 6-month period immedi- 
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ately following definitive NEPS diagnosis. All 20 pa- 
tients agreed to be interviewed and complete a health 
care utilization survey (adapted from WaIzack et al. 13). 
Health care utilization rates were established by patient 
self-report. We requested the same information from 
an available family member who was in the house- 
hold (usually a spouse or parent). When there were 
discrepancies in the information from patient and fam- 
ily member we used the lower utilization of the two 
reports. 
In addition, the hospital chart was reviewed at the 
time of inpatient seizure monitoring. Notation was 
made regarding information pertaining to recent provi- 
sion of seizure-related medical services and medication 
regime. 
RESULTS 
Inpatient video/EEG monitoring costs 
Average inpatient length of stay for the 20 NEPS study 
patients was 3.1 days (SE = 0.40, range = l-8 days, 
median days = 3.0). This is consistent with previous 
data from our center on average length of stay for NEPS 
patients, which was 2.5 days14. The average charge 
for hospitalization was $6832 (SE = 794.50; range 
= 1640-13 760; median = 7200). Total charges for 
the 20 patients were $136 640. 
Demographic information 
The final sample consisted of 14 females and 6 males 
(mean age = 36.8 years, range = 19-55). This is com- 
parable to gender distributions reported in previous 
studies which demonstrate female preponderance’, t5. 
Average duration of NEPS in this sample was 6.8 years 
(range = 6 months-33 years) with 60% of the sample 
experiencing NEPS for at least 3 years. 
Eighty-five percent of the sample were married 
(17/20), one patient was single, one patient was di- 
vorced, and one patient was separated at time of the 
inpatient monitoring. Employment status prior to in- 
patient monitoring was as follows: fulltime employed 
(2/20, lo%), not in work force (9/20,45%), receiving 
medical disability benefits for seizure disorder (4120, 
20%) and employed but on medical leave at time of as- 
sessment (5/20,25%). At 6 months following NEPS di- 
agnosis, three patients were employed fulltime (15%), 
two were part-time employed (10%) and six patients 
remained unemployed (30%). Six patients were re- 
ceiving disability payments (30%), and two patients 
remained on medical leave (10%). Overall, at time of 
post-diagnostic interview four patients had gone from 
medical leave to full/part-time employment or from 
part-time to fulltime employment. Two patients had 
begun receiving disability benefits by 6 months post- 
diagnosis. No employment category shift was present 
in 12 of the patients. 
Six of the recruited NEPS patients presented with 
histories of psychiatric diagnosis at time of inpatient 
video/EEG seizure monitoring (three with major de- 
pression, one with bipolar disorder, one with dys- 
thymia, and one with polysubstance abuse). At the time 
of hospital discharge all NEPS patients had received a 
psychiatric diagnosis (DSM-IV classification”). The 
diagnosis of conversion disorder or somatoform disor- 
der (not otherwise specified) was most often present 
while major depression, post-traumatic stress disorder, 
dissociative disorder (not otherwise specified), panic 
disorder, and borderline personality disorder were also 
psychiatric conditions diagnosed. Thirteen patients 
(65%) were receiving psychiatric/psychological inter- 
vention at 6 months following NEPS diagnosis. 
In order to determine if the study NEPS patient sam- 
ple was representative of the typical NEPS patient we 
evaluate, we compared the 24 nonparticipating NEPS 
patients from the recruitment series to the 20 study 
patients across several clinical and demographic fea- 
tures. The two groups did not differ for number of 
inpatient hospital days [r(44) = 0.56, NS]. The av- 
erage length of stay for the nonparticipating NEPS pa- 
tient was 2.8 days (SD = 1.5, range l-7 days, me- 
dian = 3 days). Groups did not differ in terms of age 
[t (44) = 0.46, NS], years of education [t (44) = 0.77, 
NS], and seizure duration (years) [t(44) = 0.46, NS]. 
In addition, the nonparticipating NEPS patients did not 
differ in terms of distribution for employment status 
[X2(6) = 0.19, NS], or marital status [X2(3) = 0.73, 
NS] from the 20 NEPS study patients. The 24 non- 
participating NEPS patients displayed a similar pro- 
portion of pre-NEPS psychiatric diagnosis (12124 pa- 
tients), and all received DSM-IV diagnostic classifica- 
tion at the time of discharge similar in classification to 
the study patients (conversion disorder, major depres- 
sion, etc.). 
At the time of NEPS diagnosis, all 20 study patients 
were experiencing seizure frequency in the poorly con- 
trolled classification (p 12 major seizures per year, or 
21 minor seizure per day)16. Previous research has 
shown that persons with poorly controlled seizures 
consume a disproportionate share of total treatment 
dollar costs compared with moderately controlled and 
well controlled seizure patients’. The NEPS patient 
group experienced an overall 69% decline in seizure 
frequency following seizure-monitoring-confirmed di- 
agnosis. Twelve patients reported experiencing at least 
90% reduction in NRPS frequency in the 6 months 
following their diagnosis. A Wilcoxon Rank Sums 
ANOVAl revealed a statistically significant decline 
in seizure frequency following NEPS diagnosis (z = 
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Table 1: Medical utilization rates for the 6-month periods before and after telemetw-based NEPS diasnosis 
Outpatient visits 
Pre-NEPS diagnosis 
No. pts using Average no. 
Service Total no. per pt (SE) 
20 180 10.4(1.8) 
Post-NEPS diagnosis 
No. pts using Average no. 
service Total no. per pt (SE) 
10 43 2.2 (0.81) 
ER kits 15 123 6.3 (2.0) 2 4 0.2fO. 14) 
Diagnostic procedures I8 55 2.9 (0.52) 6 14 0.7 (0.30) 
Laboratory tests 16 144 7.2 (31.5) 7 28 1.4 (0.62) 
Table 2: Direct medical costs for the 6-month periods before and after telemetry-based NEPS diagnosis 
Pre-NEPS diagnosis Post-NEPS diagnosis 
Total $ charges Average $ charge per pt (SE) Total $ charges Average $ charge per pt (SE) 
Outpatient visits 5983 299. I (47.6) 1350 67.5 (23.3) 
ER visits 68 152 3407 (1055) 2160 108.0 (74.3) 
Diagnostic procedures 80 207 4010 (688.3) 19087 954.7 (397.1) 
Laboratory tests 3300 180 (31.6) 700 35.0(15.4) 
Medication 12994 654.7 (131.6) 4198 209.9 (67.9) 
Average charges 8156 (1649) 1306 (440) 
3.5, p < 0.0004). No patient reported an increased 
NEPS frequency following diagnosis. Ten of the 20 
(50%) patients were no longer taking any antiepilep- 
tic medication, while six were either taking only one 
epileptic medication or lower dosages of prior seizure 
medications. One patient had been switched to another 
type of seizure medication by his primary care physi- 
cian, and one other patient was not taking antiepileptic 
medication prior to NEPS diagnosis. 
Health care utilization and charge figures 
Health care utilization rates for our NEPS sample are 
presented (see Table 1). Overall, declines were ob- 
served across the post-diagnostic 6 month time period 
for the number of outpatient physician clinic visits, 
diagnostic procedures, laboratory tests, and, most sig- 
nificantly, the number of emergency room visits. Out- 
patient clinic visits declined by an average of 80% 
(range = O-100%; median value = 95%; Wilcoxon 
test: z = 3.8, p < 0.0001). The number of diag- 
nostic procedures performed declined from a total of 
55 procedures pre-diagnosis, to 14 procedures post- 
diagnosis (Wilcoxon test: z = 3.5, p < 0.0004). 
Laboratory testing declined by 80% (Wilcoxon test, 
z = 3.1, p c 0.002). Also emergency room visits 
dropped dramatically from a total of 123 visits pre- 
diagnosis to only four visits post-NEPS diagnosis (97% 
reduction; Wilcoxon test: z = 3.4, p c 0.0007). 
Table 2 presents the change in average billable 
charges for the 6 months before and 6 months after 
NEPS diagnosis. There was an 84% average reduc- 
tion in total medical charges (medication charges, out- 
patient physician charges, emergency room charges, 
diagnostic procedure charges, and laboratory testing 
charges). Average dollar charges per patient went from 
$8156 (SE = $1649) to $1306 (SE = $440) (paired c 
test, r(l9) = 5.1, p < 0.003). Breakdown of charges 
by category can be seen in Table 2. Significant de- 
cline of 97% was seen in terms of dollar charges for 
emergency room visits (f(l9) = 3.3, p < 0.004). 
Medication dollar charges declined significantly by 
69% (t( 19) = 3.4, p < 0.003), while diagnostic test- 
ing charges declined by an average of 76% (t (19) = 
5.2, p < 0.0001). 
DISCUSSION 
This study investigated health care utilization patterns 
in patients diagnosed with NEPS following inpatient 
video/EEG seizure monitoring. The data obtained on 
the cost/utilization figures in our sample of NEPS pa- 
tients revealed substantial changes in medical costs 
and utilization rates following multidiscipIinary assess- 
ment and continuous video/EEG inpatient seizure mon- 
itoring. Specifically, downward shifts of greater than 
70% were consistently seen across multiple utilization 
categories including emergency room visits and out- 
patient clinic visits. Significant dollar costs reductions 
were also observed. This information has important 
consequences as managed care begins altering the al- 
location of ever-tightening monetary resources to man- 
age patients with epilepsy. Early identification of NEPS 
can ultimately help alleviate the financial drain to an 
already overwhelmed epilepsy clinical practice while 
initiating appropriate treatment care for NEPS popula- 
tions. 
Certainly, the treatment costs of undiagnosed NEPS 
patients would not be as high for every 6-month period, 
especially for diagnostic procedures. Many NEPS pa- 
tients were referred for inpatient assessment onfy uf- 
ter extensive outpatient diagnostic examinations had 
been petjiormed (e.g. MRI scanning, repeated ambula- 
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tory EEG monitoring). It seems reasonable to assume 
that medication cost would remain steady, as would 
frequency of ambulatory care visits, outpatient clinic 
visits and laboratory work over an extended period of 
time. This would be the expected standard of care for 
intractable epilepsy patients. The long-term financial 
value of inpatient video/EEG monitoring is in the abil- 
ity to make a definitive diagnosis. While immediate 
costs for inpatient assessment are not minor (average 
charges per inpatient evaluation were $6800) long- 
term charges (minus diagnostic testing) over a 6-year 
period (average duration of NEPS prior to diagnosis) 
could exceed $25 000 per patient. This figure represents 
the combined average charges of outpatient visits, med- 
ications, laboratory/serum work, and emergency room 
visits based upon estimates from our patient sample. 
Multiply this figure by annual incidence of NEPS3,” 
and the summated dollar costs are considerable (e.g. 
$25 000 x 100 000400 000 patients = $2.5-10 billion 
dollars). 
Our sample consisted of 20 patients deemed to have 
poorly controlled paroxysmal events. In the epilepsy 
literature, this group of ‘poorly controlled seizures’ 
patients is by far the costliest in terms of direct and 
indirect costs’. Patients with intractable epilepsy, de- 
fined as severe, frequent, and not responsive to multi- 
ple medication trials, made up 15% of their incidence 
group, but over 50% of the direct costs of treatment. 
This information indicates that NEPS patients, prior 
to definitive diagnosis, are similar in terms of medi- 
cal utilization and dollar costs to persons with severe 
intractable epilepsy. 
NEPS is a diagnosable, although not easily identifi- 
able, psychiatric condition commonly seen in general 
neurology outpatient practice6. Research has repeat- 
edly demonstrated the critical importance of inpatient 
video/EEG seizure monitoring in the definitive diagno- 
sis of this condition99 lg. The importance of video/EEG 
seizure monitoring is well established when related 
to appropriate diagnosis. With definitive diagnosis a 
dramatic shift of treatment modalities (e.g. antide- 
pressant medication, psychotherapy) can be initiated 
which focus upon the more psychological/emotional 
aspects of the condition ‘*. Furthermore, research has 
demonstrated the long-term cost- effectiveness of men- 
tal health care within the broader medical managed care 
domain’9,20. 
Certainly, definitive statements regarding the cost- 
effectiveness of early video/EEG-seizure-monitoring- 
based diagnosis of NEPS cannot be elicited from this 
small sample group. However, this study was intended 
to document the potential for cost savings in a pa- 
tient group that utilizes medical resources at high rates. 
More sophisticated prospective investigations employ- 
ing cost-effectiveness analysis will certainly need to 
be pet-formed*‘. In addition, beyond documenting cost 
savings within the epilepsy community, this type of 
analysis should lead to the development of decision 
models for determining when inpatient video/EEG 
seizure monitoring is the most cost-effective technol- 
ogy for the diagnosis and treatment of NEPS. The ex- 
tent to which successful management of NEPS leads to 
changes in nonNEPS health care resource use should 
also be analyzed. Finally, outcomes of care, including 
Quality of Life, should be assessed and included in the 
analysis. 
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